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CASE REPORT
A pyoderma gangrenous‑like 
cutaneous leishmaniasis in a Libyan woman 
with rheumatoid arthritis: a case report
Hamida Al‑Dwibe1, Ahmad Amro2* , Aisha Gashout3, Ali El‑Zurghany1, Said El‑zubi1, Mohamed El‑Hashme1, 
Omar Hamarsheh4 and Mokhtar Maree1
Abstract 
Background: Several case reports describe diseases presenting with skin ulcerations, which resemble pyoderma 
gangrenosum especially in immune‑compromised patients, often proven on further workup, to have an infective or 
malignant etiology. However, treatment of pyoderma gangrenosum by systemic steroids or other immunosuppres‑
sive agents may worsen the condition.
Case presentation: We report here, a 45 year‑old Libyan woman with rheumatoid arthritis on low dose steroids with 
pyoderma gangrenosum‑like skin lesions and positive pathergy. Slit–smear was positive for Leishmania amastigotes 
and histopathological examination confirmed the diagnosis of cutaneous leishmaniasis. The lesions healed com‑
pletely by parenteral sodium stibogluconate (Pentostam) 600 mg daily.
Conclusion: We report for the first time, a rare and unusual presentation of pyoderma gangrenosum like‑cutaneous 
leishmaniasis in a patient with rheumatoid arthritis. Atypical cutaneous leishmaniasis should not be ruled out in the 
differential diagnosis of unresponsive skin diseases, with slit/smear and a skin biopsy is required.
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Background
Cutaneous leishmaniasis (CL) is a protozoan skin infec-
tion caused by various species of Leishmania parasites 
and transmitted by correspondent species of sand flies. 
CL is highly endemic in Libya especially after the armed 
conflict that outbreak in the country [1]. CL has a wide 
clinical spectrum, presenting in different clinical forms 
of the disease depending particularly on host immune 
response rather than on the parasite species [2, 3]. How-
ever, there are some clinical manifestations that are more 
prevalent in one host than in another [4, 5]. Unusual 
clinical variants of CL include mucocutaneous leishma-
niasis (MCL), diffuse cutaneous leishmaniasis (DCL), 
disseminated cutaneous leishmaniasis (DCL), and leish-
maniasis recidivans (LR). Rare forms of CL were reported 
with sporotrichoid, psoriasiform, and zosteriform [2, 6, 
7]. In immune-compromised patients, skin ulcerations 
are often associated with infections or malignancy [8]. 
However, treatment of pyoderma gangrenous by systemic 
steroids or other immunosuppressive drugs proved to 
worse the condition. Herein, we report for the first time, 
a rare and unusual presentation of PG like CL in a patient 
with rheumatoid arthritis (RhA).
Case presentation
A 46-year-old, women from Tawirgha, Libya was referred 
to the Leishmaniasis Clinic, Tripoli Central Hospital. She 
was admitted to the clinic with multiple papules, pus-
tules, ulcerated nodules, and painful ulcerative lesions 
over upper and lower extremities for 2 years. The lesions 
started as painful papules and pustules, which gradually 
enlarged in size, and eventually ulcerated with pus dis-
charge. Her worsened conditions, prompted her to seek 
advanced medical care. Two years later, the patient had 
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been admitted twice to the hospital in her local village 
for the same problem. She was treated with topical and 
systemic antibiotics without any improvement, so she 
was referred to the Leishmaniasis Clinic in Tripoli Cen-
tral Hospital. The patient had suffered from rheumatoid 
arthritis for 22  years, hypertension, and diabetes melli-
tus and has been prescribed a low dose of prednisolone 
(20  mg/days) for 20-years, beta-1 selective adrenergic 
antagonist, and an oral antihyperglycaemic medication.
No previous history of trauma or insect bites were 
reported by the patient. However, she had a history of 
CL in the buttocks, which was treated with intra-lesional 
injections of pentostam.
Physical examination revealed good general condition, 
a red puffy face with telangiectasia over both checks and 
mild lower limb edema. On cutaneous examination, the 
patient was found to have multiple erythematous pap-
ules, pustules, and ulcerated nodules as well as painful 
well defined erythematous ulcers of varying sizes with 
raised irregular indurated margins on both forearms 
(Fig.  1a) and multiple painful punched out ulcers on 
lower limbs (Fig.  1b). The base of ulcers contained yel-
lowish exudate and necrotic yellowish slough (Fig.  1a, 
b). The ulcers on extensor and flexore surfaces on the 
right leg was associated with swelling of the leg with sur-
rounding skin inflammation (Fig.  1b). In addition, large 
hypo pigmented atrophic scare surrounded by a rim of 
hyper-pigmentation over the right buttock (healed CL 
lesions), and pustules at site of injections were observed 
(pathergy) (Fig. 1c).
Skin examination revealed ulcers presenting as PG, or 
as vasculitic ulcers secondary to Rh.A or an unusual vari-
ant of CL. Routine hematological investigations revealed 
elevated white blood cell count (12.3 × 109/l), hemo-
globin level of 11.7  g/dl, platelet counts of 230 × 109/l, 
ESR 15/h, CRP of 54  mg/l, FBS of 135  mg/dl and high 
levels of transaminases (GGT 528 U/l, GPT 80 U/l). 
Renal function tests, rheumatoid factor, and cortisol 
were at normal levels. Ultrasonography examination of 
the abdomen revealed enlarged liver with marked fatty 
changes. Serologic tests for HIV and viral hepatitis were 
negative. Chest radiograph, ECG, and Echo were normal.
A skin biopsy obtained from the lesions revealed hyper-
keratosis, focal parakeratosis, acanthosis, spongiosis, and 
exocytosis. Dermis showed heavy diffuse granulomatous 
infiltrate composed of epithelioid cells, and lymphocytes 
admixed with plasma cells, neutrophils, and mast cells 
with some extravasated RBCs (Fig.  2a). A perivascular 
chronic inflammatory cell infiltrate with extravasated 
RBCs, nuclear dust, thickening of endothelium and fibri-
noid necrosis of few blood vessels and few Leishmania 
parasites was seen especially in biopsies obtained from 
leg ulcers. However, biopsies taken from the papulo–pus-
tular lesions showed many Leishmania parasites inside 
and outside the macrophages (Fig. 2b). Molecular identi-
fication of the causative Leishmania spices was not done.
The patient was treated with systemic antibiotics, and 
sodium stibogluconate (Pentostam) (600  mg daily-I.M) 
was started after reduction of the transaminases enzymes 
by stopping all medications that have been used by the 
patient for long time. Complete healing of lesions was 
achieved after 15 days, except a small erythematous pap-
ule on the left forearm which was treated by cryotherapy. 
After 2 years follow up, no relapse was noted. The impor-
tant milestones related to diagnosis, interventions and 
follow up of this case are listed in Additional file 1.
Discussion and conclusions
Cutaneous leishmaniasis has been endemic in North-
western regions of Libya for a long time. The incidence 
of this infection is rising since the year of 1971, and new 
foci have been reported recently [5]. Clinically, CL can 
Fig. 1 Deep ulcers on different regions of the patient extremities. a Multiple well defined erythematous ulcers with raised irregular indurated 
margins on one of the forearms. b Ulcers on flexural surfaces of the right leg associated with swollen inflamed surrounding skin. c A large hypo 
pigmented atrophic scar surrounded by a rim of hyperpigmentation over right buttock (healed CL lesions)
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resemble many skin diseases such as bacterial skin infec-
tions, fungal skin infections, mycobacterial infections, 
eczema, sarcoidosis, insect bites, and malignancies like 
basal and squamous cell carcinomas, and can be misdi-
agnosed as other diseases [9, 10]. When the ulcerating 
lesion of CL is located on the extremities especially legs, 
other diseases like pyoderma gangrenosum, a typical 
mycobacterial infection, venous, and arterial ulcers must 
be considered in the differential diagnosis [6]. In addi-
tion, venous, infective, and inflammatory leg ulcers such 
as vasculitis or pyoderma gangrenosum may develop 
in patients with rheumatoid arthritis. These ulcers are 
often painful, difficult to heal, and may last for years as 
described in this case.
The clinical diagnosis of CL was suspected since this 
patient came from an endemic area, having multiple 
lesions on exposed parts of body, not responding to 
treatment with antibiotics, had positive personal and 
family history of CL which are confirmed as risk fac-
tors for CL [11, 12] as well as confirmation of the case 
by a slit–skin smear and histopathological examina-
tion. The reason for this rare unusual clinical type of 
Pyoderma gangrenosum like CL is unknown and raises 
speculation and assumptions about the host parasite 
relationship and the capacity of Leishmania parasites 
to modulate the host immune response [13–16]. The 
infection by specific Leishmania strains, and an altered 
host immune response caused by systemic administra-
tion of steroid drugs may have a role for persistence 
of the lesions. However, patients on systemic corti-
costeroids are likely to be immune-compromised with 
increased susceptibility to infections, particularly 
with intra-cellular microorganisms, which may lead to 
the development of unusual types of leishmaniasis as 
explained by the blockade of cytokine expression by 
glucocorticoids released from T lymphocyte cells [17]. 
Pentavalent antimony compounds such as sodium sti-
boglyconate and meglumine antimoniate still remain 
the first choice for the treatment of CL [2–4, 6, 7, 18]. 
Sodium stiboglyconate 600 mg/day intramuscularly for 
15 days was sufficient to completely heal the lesions in 
this case.
Atypical CL should not be ruled out in the differential 
diagnosis of unresponsive skin diseases, with slit/smear 
and a skin biopsy being required. Moreover, history of 
previous exposure to sand fly bites or previous Leish-
mania infection may help in the diagnosis. According 
to the author’s knowledge, this case represented the 
first reported case of CL presenting as pyoderma gan-
grenosum like lesions in Libya.
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